glp-1 news updates november 2025 Drug Side Effects May Be Tackled with More Mechanistic Studies Trump administration secures deal to

People taking GLP-1s are a self-selecting group of people making a conscious and costly decision to try to improve their health

Heres what she shared: Because Ro doesnt offer a comprehensive weight loss program, like Noom or WeightWatchers, its a better fit for people who are already working with a registered dietitian or enrolled in a weight loss program

Studies in patients with type 2 diabetes and obesity have demonstrated that the use of SGLT2 inhibitors, particularly empagliflozin, not only increases overall cancer risk but also significantly elevates the risk of bladder cancer [10, 108]

Hers is the sister platform for women, operating under the same Hims & Hers Health umbrella

Medical Weight Loss When it comes to being a healthier version of yourself, it isnt solely about a number on the scale